<p>RCAS-Neu breast cancer cells (5×10<sup>5</sup>) in a 50 ml volume were mixed with equal volume of PBS or MSCs (1×10<sup>5</sup> or 5×10<sup>5</sup> cells.) The mixture (100 µl/mouse) was injected into the fat pad of female FVB mice (6–8 wks of age). Tumor size was measured twice weekly with a calipers.</p
<p>(A) Mice were implanted with ten million cells with the SW1088 or CCF-STTG1 cells. The starting t...
<p>(A)To assess the effects of siRNA therapy on tumor growth, treatment was initiated 1 wk after i.p...
<p><b><i>1A</i></b><i>,</i> representative FACS plots for MDSC in blood, BM, spleen and tumor of 3LL...
<p>Different numbers of 4T1 breast carcinoma cells (A: 10<sup>5</sup>; B and D: 10<sup>4</sup>; C:10...
<p>Female TVA transgenic mice (8–10 weeks old) were infected by intraductal injection of RCAS-PyMT v...
<p>(a,b) To assess cell proliferation, 4T1 or JC cells were cultured in RPMI-1640 medium or MSC-CM w...
<p>The established syngeneic mouse model for epithelial ovarian cancer used is based upon a spontane...
<p>(A) MTT assay of breast tumor cell proliferation. RCAS-Neu, RCAS-PyMT, and 4T1 cells were culture...
<p>MSCs were grown in the complete DMEM medium mixed with equal volume of RPMI 1640 media or with co...
<p>(<b>A</b>) MS17-57 mAb inhibits the growth of MKN45 tumor cell xenografts. Cells (1x10<sup>6</sup...
<p>The tumor growth inhibition analysis in nude mice bearing Bel-7402 tumors after injection of vari...
<p>(A) C57BL/6 mice were injected subcutaneously with 1×10<sup>6</sup> McgR32 cellsand 8 day later, ...
<p><b>a</b>, Mice bearing BT483-derived breast cancer xenografts with average tumor size of ∼75 mm<s...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>(A) Tumor volume fold change over time (14 days). Decrease in mean tumor volume + SEM was observe...
<p>(A) Mice were implanted with ten million cells with the SW1088 or CCF-STTG1 cells. The starting t...
<p>(A)To assess the effects of siRNA therapy on tumor growth, treatment was initiated 1 wk after i.p...
<p><b><i>1A</i></b><i>,</i> representative FACS plots for MDSC in blood, BM, spleen and tumor of 3LL...
<p>Different numbers of 4T1 breast carcinoma cells (A: 10<sup>5</sup>; B and D: 10<sup>4</sup>; C:10...
<p>Female TVA transgenic mice (8–10 weeks old) were infected by intraductal injection of RCAS-PyMT v...
<p>(a,b) To assess cell proliferation, 4T1 or JC cells were cultured in RPMI-1640 medium or MSC-CM w...
<p>The established syngeneic mouse model for epithelial ovarian cancer used is based upon a spontane...
<p>(A) MTT assay of breast tumor cell proliferation. RCAS-Neu, RCAS-PyMT, and 4T1 cells were culture...
<p>MSCs were grown in the complete DMEM medium mixed with equal volume of RPMI 1640 media or with co...
<p>(<b>A</b>) MS17-57 mAb inhibits the growth of MKN45 tumor cell xenografts. Cells (1x10<sup>6</sup...
<p>The tumor growth inhibition analysis in nude mice bearing Bel-7402 tumors after injection of vari...
<p>(A) C57BL/6 mice were injected subcutaneously with 1×10<sup>6</sup> McgR32 cellsand 8 day later, ...
<p><b>a</b>, Mice bearing BT483-derived breast cancer xenografts with average tumor size of ∼75 mm<s...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>(A) Tumor volume fold change over time (14 days). Decrease in mean tumor volume + SEM was observe...
<p>(A) Mice were implanted with ten million cells with the SW1088 or CCF-STTG1 cells. The starting t...
<p>(A)To assess the effects of siRNA therapy on tumor growth, treatment was initiated 1 wk after i.p...
<p><b><i>1A</i></b><i>,</i> representative FACS plots for MDSC in blood, BM, spleen and tumor of 3LL...
DOI
Add to ORKG